Masakazu Sugiyama

The neuroprotective effect of a potent and selective inhibitor of type I NOS (L-MIN) in a rat model of focal cerebral ischaemia

Toshiaki Nagafuji, Masakazu Sugiyama, Atsushi Muto et al. · Neuroreport · 1995 · 55 citations

Rat Model, Social Sciences, Neuroprotective Effect +22

Inhibin βE (INHBE) is a possible insulin resistance-associated hepatokine identified by comprehensive gene expression analysis in human liver biopsy samples

Masakazu Sugiyama, Akihiro Kikuchi, Hirofumi Misu et al. · PLoS ONE · 2018 · 53 citations · Full text

Immunology, Pathology, Dna Chip Method +17

Nitric oxide synthase in cerebral ischemia

Toshiaki Nagafuji, Masakazu Sugiyama, Toru Matsui et al. · Molecular and Chemical Neuropathology · 1995 · 48 citations

Cerebral Ischemia, Ischemic Stroke, Neurophysiology +12

High expression of the Notch ligand Jagged‐1 is associated with poor prognosis after surgery for colorectal cancer

Masakazu Sugiyama, Eiji Oki, Yu Nakaji et al. · Cancer Science · 2016 · 39 citations · Full text

A narrow therapeutical window of a nitric oxide synthase inhibitor against transient ischemic brain injury

Toshiaki Nagafuji, Masakazu Sugiyama, Toru Matsui et al. · European Journal of Pharmacology Environmental Toxicology and Pharmacology · 1993 · 27 citations

Cerebral Vascular Regulation, Ischemic Stroke, Nitrosative Stress +12